Abstract
Fungal keratitis is a severe ocular infection that primarily affects subjects engaged in outdoor activities. Risk factors include allergic conjunctivitis, previous eye surgery, previous treatment with wide-spectrum antimicrobial agents and corticosteroids and using contact lenses. Corneal infection is usually secondary to trauma involving organic material, which is often the only predisposing factor. Early diagnosis based on clinical examination and microbiological investigation (microscopy, cultures and molecular techniques) is crucial to selecting the appropriate antifungal therapy and prevent progression. We report the case of a patient with keratitis due to Beauveria bassiana, an opportunistic and entomopathogenic filamentous fungus that is used as a biological insecticide and which is a rare cause of corneal infection. We review previous cases reports of B. bassiana keratitis published and its main features to compare with our case, a female occasional agriculture worker who had not suffered any trauma involving organic material. The patient received topical and oral antifungal therapy and debridement surgery, with a satisfactory outcome.
Similar content being viewed by others
References
Ligozzi M, Maccacaro L, Passilongo M, Pedrotti E, Marchini G, Koncan R, et al. A case of Beauveria bassiana keratitis confirmed by internal transcribed spacer and LSU rDNA D1–D2 sequencing. New Microbes New Infect. 2014;2:84–7.
Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19:210–20.
Tucker DL, Beresford CH, Sigler L, Rogers K. Disseminated Beauveria bassiana infection in a patient with acute lymphoblastic leukemia. J Clin Microbiol. 2004;42:5412–4.
García Lozano T, Aznar Oroval E, Pérez Ballestero P, Lorente Alegre P. Isolation of Beauveria bassiana in a bronchoalveolar lavage specimen from a patient with bladder cancer. Rev Iberoam Micol. 2011;28:198–9.
Henke MO, de Hoog GS, Gross U, Zimmermann G, Kraemer D, Weig M. Human deep tissue infection with an entomopathogenic Beauveria species. J Clin Microbiol. 2002;40:2698–702.
Figueira L, Pinheiro D, Moreira R, Pinto E, Simões J, Camisa E, et al. Beauveria bassiana keratitis in bullous keratopathy: antifungal sensitivity testing and management. Eur J Ophthalmol. 2012;22:814–8.
Kisla TA, Cu-Unjieng A, Sigler L, Sugar J. Medical management of Beauveria bassiana keratitis. Cornea. 2000;19:405–6.
Sonoyama H, Araki-Sasaki K, Kazama S, Kawasaki T, Ideta H, Sunada A, et al. The characteristics of keratomycosis by Beauveria bassiana and its successful treatment with antimycotic agents. Clin Ophthalmol. 2008;2:675–8.
Alastruey-Izquierdo A, Mellado E, Peláez T, et al. Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP STUDY). Antimicrob Agents Chemother. 2013;57:3380–7.
Mitani A, Shiraishi A, Miyamoto H, Sunada A, Ueda A, Asari S, et al. Fungal keratitis caused by Beauveria bassiana: drug and temperature sensitivity profiles: a case report. BMC Res Notes. 2014;7:677.
Dahlgren MA, Lingappan A, Wilhelmus KR. The clinical diagnosis of microbial keratitis. Am J Ophthalmol. 2007;143:940–4.
Ishibashi Y, Kaufman HE, Ichinoe M, Kagawa S. The pathogenicity of Beauveria bassiana in the Rabbit Cornea. Mycoses. 1987;30:115–26.
de Hoog GS, Guarro J, Tan CS, Wintermans RGF, Gené J. Hyphomycetes. In: de Hoog GS, Guarro J, Gené J, Figueras MJ, editors. Atlas of clinical fungi. 2nd ed. Baarn: Centraalbureau voor Schimmelcultures; 2000. p. 380–1007.
Qiu S, Zhao GQ, Lin J, Wang X, Hu LT, Du ZD, et al. Natamycin in the treatment of fungal keratitis: a systematic review and Meta-analysis. Int J Ophthalmol. 2015;8:597–602.
Sedo S, Iribarne Y, Fossas M, Vendrell C, Ortiz F. Queratitis fúngica. Ann d’Oftalmol. 2003;11:168–75.
Rahman MR, Minassian DC, Srinivasan M, Martin MJ, Johnson GJ. Trial of chlorhexidine gluconate for fungal corneal ulcers. Ophthalmic Epidemiol. 1997;4:141–9.
Rahman R, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2 % chlorhexidine gluconate and 2.5 % natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol. 1998;82:919–25.
Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, et al. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc. 2003;101:183–90.
Yoo SH, Dursun D, Dubovy S, Miller D, Alfonso E, Forster RK, et al. Lontophoresis for the treatment of Paecilomyces keratitis. Cornea. 2002;21:131–2.
Sharma N, Agarwal P, Sinha R, Titiyal JS, Velpandian T, Vajpayee RB. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series. Br J Ophthalmol. 2011;95:1735–7.
Sachs SW, Baum J, Mies C. Beauvaria bassiana keratitis. Br J Ophthalmol. 1985;69:548–50.
Low CD, Badenoch PR, Coster DJ. Beauveria bassiana keratitis cured by deep lamellar dissection. Cornea. 1997;16:698–9.
Tu EY, Park AJ. Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil). Cornea. 2007;26:1008–10.
Oh JY, Lee MJ, Wee WR, Heo JW. A case of necrotizing sclerokeratitis and endophthalmitis caused by Beauveria bassiana. Jpn J Ophthalmol. 2009;53:551–3.
Pariseau B, Nehls S, Ogawa GSH, Sutton DA, Wickes BL, Romanelli AM. Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison. Cornea. 2010;29:152–8.
Ogawa A, Matsumoto Y, Yaguchi T, Shimmura S, Tsubota K. Successful treatment of Beauveria bassiana fungal keratitis with topical voriconazole. J Infect Chemother. 2016;22:257–60.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors certify no conflicts of interest in relation to this article exist.
Rights and permissions
About this article
Cite this article
Lara Oya, A., Medialdea Hurtado, M.E., Rojo Martín, M.D. et al. Fungal Keratitis Due to Beauveria bassiana in a Contact Lenses Wearer and Review of Published Reports. Mycopathologia 181, 745–752 (2016). https://doi.org/10.1007/s11046-016-0027-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-016-0027-2